Last reviewed · How we verify

NCT05471037: SLIM - Part 3

Different Limb Lengths in Gastric Bypass Surgery (SLIM) - Part 3: Metabolism and Inflammation

Recruiting now NA Last updated 28 January 2025
What this trial tests

NA trial testing Long Biliopancreatic Limb LRYGB in Obesity, Morbid in 65 participants. Currently enrolling.

Timeline
1 August 2022
Primary endpoint
1 January 2026
1 January 2026

Quick facts

Lead sponsorUniversity Hospital, Basel, Switzerland
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Enrollment65
Start date1 August 2022
Primary completion1 January 2026
Estimated completion1 January 2026
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Basel, Switzerland

Who can join

Adults 18 to 65, any sex, with Obesity, Morbid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigation of underlying metabolic mechanisms and impact on the two surgical procedures on inflammatory factors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obesity, Morbid

Currently open trials in the same condition.

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05471037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing